SCHEMBL5148788

SCHEMBL5148788

C[Si](C)(C)Cl.OCCc1ccsc1Cc1ccc(F)cc1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.35
MAPT P10636 4/20 0.35
HPGD P15428 2/20 0.35
LMNA P02545 2/20 0.35
ALDH1A1 P00352 2/20 0.35
GAA P10253 1/20 0.35
PKM P14618 1/20 0.35
SMN1; SMN2 Q16637 6/20 0.34
TP53 P04637 5/20 0.34
RAB9A P51151 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
TAAR1 Q96RJ0 1/20 0.33
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
ABL1 P00519 1/20 0.32
LTB4R Q15722 1/20 0.32
POLB P06746 2/20 0.31
TRPA1 O75762 1/20 0.30
NPC1 O15118 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2976063 0.91 PTGS1 (0.41) PTGS1MAPTHPGDLMNAALDH1A1
SCHEMBL2985695 0.74 HPGD (0.34) MAPTHPGDLMNAALDH1A1GAA
SCHEMBL2988533 0.69 SIGMAR1 (0.45) L3MBTL1
SCHEMBL8306828 0.69 ALDH1A1 (0.47) PTGS1MAPTHPGDLMNAALDH1A1
SCHEMBL27555980 0.68 MEN1 (0.31) ALDH1A1
SCHEMBL18723898 0.66 TMEM97 (0.36) MAPTHPGDLMNAALDH1A1SMN1; SMN2
SCHEMBL10787556 0.66 CA2 (0.52) PTGS1MAPTALDH1A1GAATAAR1
SCHEMBL28468260 0.65 PTGS1 (0.38) PTGS1MAPTHPGDLMNAALDH1A1
SCHEMBL8304165 0.65 MAPT (0.40) PTGS1MAPTHPGDLMNAALDH1A1
SCHEMBL24938229 0.65 TAAR1 (0.40) PTGS1MAPTHPGDLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831207-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2007-09-12 EP disclosed
WO-2006066172-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE AMGEN, INC. (US) 2006-06-22 WO disclosed